Applications of 2-(2,3-Dichlorophenyl)-2-Guanidinyliminoacetonitrile in Industrial Manufacturing

As the original manufacturer of 2-(2,3-Dichlorophenyl)-2-Guanidinyliminoacetonitrile, we serve customers across various niche industrial domains where this specialty intermediate plays a decisive role in regulated downstream production. Each sector listed below reflects direct market feedback and longstanding supply partnerships. The following breakdown details real-world adoption paths, focusing on the unique operational practices, compliance requirements, and formulation parameters observed at customer plants worldwide.

1. Active Pharmaceutical Ingredient (API) Synthesis – Antimicrobial Drug Segment

Major pharmaceutical companies incorporate this compound as a core guanidine-based building block for the synthesis of third-generation antimicrobial APIs targeting resistant Gram-negative bacterial strains. Its high reactivity and electronic configuration enable direct coupling with heterocyclic scaffolds under carefully controlled conditions common to established GMP facilities, ensuring batch-to-batch purity and regulatory acceptance.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• European Pharmacopoeia Monographs 10th Edition (Ph. Eur.)
• US FDA 21 CFR Part 211 (cGMP for Finished Pharmaceuticals)

Typical usage ratio

• 0.7–1.4 molar equivalents in final API synthesis, adjusted based on target yield, impurity profile, and molecular weight of the drug substance

Downstream process integration

• Reacted in the key condensation step following initial substrate activation, typically after solvent purification and substrate pre-treatment under inert conditions.

Final product types

• Oral and parenteral antimicrobial APIs (e.g., new guanidine-derivative antibiotics)
• Bulk drug intermediates for further formulation in tablet and injectable dosage forms

2. Specialty Agrochemical Synthesis – Herbicide Intermediate

Leading agrochemical manufacturers select this compound as an intermediate for the construction of new-generation phenyl-guanidine herbicides targeting broad-leaf weeds in cereal crops. Its dichlorinated aromatic ring structure confers resistance to environmental degradation, ensuring the final active ingredient retains field potency throughout the growing cycle. The integration protocol aligns with established batch and continuous processing setups, with rigorous environmental monitoring at scale.

Industry compliance standards

• OECD Principles of Good Laboratory Practice (GLP)
• FAO/WHO JMPR Residue Standards
• ISO 9001:2015 Quality Management for Agrochemical Production

Typical usage ratio

• 10–13% by weight of total reactant mass during herbicide active ingredient build-up, adjusted to compensate for reactivity losses during chlorination steps

Downstream process integration

• Charged directly after initial chlorination and before cyclization, typically at the pre-crystallization stage to fix the guanidine moiety onto the chlorinated phenyl core

Final product types

• Concentrated herbicide actives for granule and suspension concentrate formulations
• Custom pre-mix herbicidal blends for regional regulatory submission

3. Specialty Polymer Additive Synthesis – Electrically Conductive Resin Modification

Manufacturers of functional polymers integrate this molecule as a chain-extension promoter in synthetic routes for antistatic and conductive resin systems. Its interaction with electron-deficient resin backbones enables fine-tuning of surface and volume resistivity in engineered composites, especially for electronics packaging and ESD-sensitive applications. Each processing stage maintains strict in-process control using online conductivity measurement.

Industry compliance standards

• RoHS 2011/65/EU (Restriction of Hazardous Substances in Electronics)
• IEC 61340-5-1 ESD Control Programs
• ISO 14001 Environmental Management Systems for Polymer Manufacturing

Typical usage ratio

• 1.2–3.8% by weight within the reaction mass for chain extension, optimized according to target volume resistivity and polymer backbone chemistry

Downstream process integration

• Dosed into the reactor after resin pre-polymerization but before catalyst addition, permitting direct nucleophilic addition under nitrogen with in-line homogenization

Final product types

• Antistatic masterbatches for electronic packaging films
• Conductive engineering plastics and ESD-safe trays

4. Specialty Dye and Pigment Manufacture – Fastness Enhancer for Cationic Dyes

Producers of cationic dyes for the textiles and paper industries use this compound at the coupling stage to improve dye–fiber affinity and enhance wash fastness properties. Its guanidinyl functional group strengthens ionic bonding to cellulose and polyamide substrates, resulting in reduced dye migration during post-treatment rinsing. Control of pH and temperature during integration directly influences dye shade and leveling.

Industry compliance standards

• OEKO-TEX® Standard 100 – Product Class I–IV/Application in Textiles
• ZDHC Manufacturing Restricted Substances List (MRSL)
• REACH Regulation (EC) No 1907/2006 for Dye and Pigment Ingredients

Typical usage ratio

• 0.8–1.6% by weight of total dye formulation, adjusted for target depth of shade and substrate chemistry

Downstream process integration

• Added after primary diazo coupling, within the final salt formation stage, under cooled agitation to avoid unwanted byproduct formation

Final product types

• Cationic dyes for direct and continuous dyeing of cellulosic fibers
• High-fastness paper and textile pigment concentrates

5. Veterinary API Manufacturing – Antiprotozoal Active Ingredient Precursor

Veterinary drug manufacturers employ this compound to synthesize active ingredients for antiprotozoal treatments, especially those used in livestock applications targeting coccidiosis and similar parasitic infections. Stringent control of precursor purity ensures the absence of residual byproducts in final API lots, in compliance with animal health safety standards. Downstream formulation integrates the finished active into bulk powders and solutions for oral administration.

Industry compliance standards

• VICH GL9 Good Manufacturing Practice for Veterinary Products
• EU Regulation (EU) 2019/6 on Veterinary Medicinal Products
• China Veterinary Pharmacopoeia 2020 Edition

Typical usage ratio

• 0.5–1.2 equivalents based on final active content, adjusted for protozoal target and formulation route

Downstream process integration

• Chemically coupled in the pre-final cyclization phase, prior to purification and crystallization of the veterinary API

Final product types

• Antiprotozoal premixes and water-soluble powders for feed-grade additions
• Oral suspensions for direct livestock treatment